Lamogin 50 mg Tablet is a versatile primary anti-epileptic medication used for the management of seizures and bipolar disorder in adults and children. It is particularly effective in partial-onset seizures, primary generalized tonic-clonic seizures, and generalized seizures associated with Lennox-Gastaut syndrome. Additionally, Lamogin 50 mg is indicated for the treatment of bipolar disorder in adults. It functions by stabilizing neuronal membranes and regulating neurotransmitter release, thereby controlling hyperexcitable neurons.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Primary anti-epileptic drugs

Indications

Lamogin 50 mg is indicated for:

• Epilepsy – Combination Therapy:

  • Patients aged 2 years and older

  • Partial-onset seizures

  • Primary generalized tonic-clonic seizures

  • Generalized seizures associated with Lennox-Gastaut syndrome

• Epilepsy – Monotherapy:

  • Patients aged 16 years and older

• Bipolar Disorder:

  • Adults as monotherapy or adjunctive therapy

Pharmacology

Lamogin 50 mg works primarily by inhibiting voltage-sensitive sodium channels, which stabilizes neuronal membranes. This action reduces the presynaptic release of excitatory neurotransmitters such as glutamate and aspartate, thereby controlling epileptic seizures and stabilizing mood in bipolar disorder. It also exhibits weak interactions with multiple neurotransmitter receptors, including serotonin, dopamine, GABA, histamine, adrenergic, and opioid receptors, which may contribute to its broader clinical effects.

Dosage & Administration

Epilepsy – Adults & Children ≥16 years (Monotherapy)

• Start: 25 mg once daily for 14 days

• Increase: 50 mg once daily for next 14 days

• Titrate: Increase by 50 mg/day every 7–14 days

• Maintenance: 225–375 mg/day in 1–2 divided doses

Adjunctive Therapy (with Valproate)

• Adults & children >12 years: 25 mg alternate days → 25 mg daily → titrate 25–50 mg/day

• Children 2–12 years: 150 mcg/kg/day → 300 mcg/kg/day → titrate to 1–3 mg/kg/day

Adjunctive Therapy (with enzyme-inducing drugs)

• Adults & children >12 years: 50 mg daily → 50 mg twice daily → titrate 100 mg/day increments

• Children 2–12 years: 600 mcg/kg/day → 1.2 mg/kg/day → titrate to 5–15 mg/kg/day (max 400 mg/day)

Bipolar Disorder – Adults

• Monotherapy without Valproate: Start 25 mg → 50 mg → 100 mg → maintenance 200 mg daily

• With Valproate: Start 25 mg alternate days → 25 mg → 50 mg → maintenance 100 mg daily

• With enzyme-inducing drugs: Titrate to 200 mg twice daily

Administration Tips:

• Take orally, with or without food.

• Gradual titration reduces risk of side effects.

• For intravenous use, follow prescribed protocols in hospital settings.

Drug Interactions

• Oral contraceptives: may reduce efficacy

• Anticonvulsants: Carbamazepine, Phenytoin, Phenobarbital, Primidone

• Other drugs: Levetiracetam, Lithium, Lopinavir/ritonavir, Olanzapine, Pregabalin

• Monitor for additive CNS effects and PR interval prolongation

Contraindications

• Hypersensitivity to Lamogin or its ingredients

• History of rash, angioedema, acute urticaria, or mucosal ulceration

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common adverse effects include:

• Dizziness, tremor, headache, blurred vision

• Nausea, vomiting, diarrhea, abdominal pain

• Sleepiness, insomnia, fatigue, lack of coordination

• Rash, fever, infections, back pain

• Serious but rare: suicidal ideation, blood dyscrasias, aseptic meningitis, severe skin reactions

Pregnancy & Lactation

• Pregnancy Category C: Use only if benefits outweigh risks

• Present in breast milk; nursing mothers should consult a physician

Precautions & Warnings

• Monitor for suicidal behavior, serious skin rashes, blood dyscrasias, and aseptic meningitis

• Gradual withdrawal recommended to prevent seizure exacerbation

• Use caution in patients with hepatic or renal impairment

Overdose Effects

• Ataxia, nystagmus, seizures, decreased consciousness

• Coma and intraventricular conduction delay in severe cases

Storage Conditions

• Store below 30°C in a dry, light-protected place

• Keep out of reach of children

Special Populations

• Hepatic impairment: Dose adjustments required

• Renal impairment: Reduced maintenance doses may be effective

• Pediatric safety: Not established for children under 2 years for epilepsy or under 10 years for bipolar disorder

Mode of Action

• Inhibits voltage-sensitive sodium channels

• Stabilizes neuronal membranes

• Modulates presynaptic release of excitatory neurotransmitters

• Weak interactions with multiple neurotransmitter receptors may contribute to anticonvulsant and mood-stabilizing effects.